Hims & Hers Health, Inc.

XNYSHealth care

Last traded price · USD

$26.80

+4.28%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: $25.92
Previous close: $25.70
Volume: 11.6M
Day's high: $28.66
Day's low: $25.92

In brief

Hims & Hers Health, Inc. is a health care company listed on the New York Stock Exchange, valued at about $6.25B.
Its shares closed at $26.66 on 4 Nov 2026, down 37.7% over the past year.
From India you can buy HIMS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Hims & Hers Health, Inc. (HIMS) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole HIMS share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade HIMS options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: −9.5% (SPY −1.6%). 3 months: −15.8% (SPY −0.4%). 1 year: −37.7% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: HIMS, SPY · as of 4 Nov 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $26.66 was 7.0% below its 50-day average ($28.66) and 1.1% below its 200-day average ($26.95). It has closed below the 200-day for 3 sessions, since 2 Nov 2026. The 50-day average crossed above the 200-day on 30 Jul 2026, 68 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
5.0 days to cover short interest
53.5M shares were sold short at the 15 Oct 2026 settlement, 23.8% of the 224.9M shares outstanding; covering them would take 5.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
43% of the way up its 52-week range
Closed at $26.66 on 4 Nov 2026: 39.4% below the 52-week high of $44.00 (6 Nov 2025) and 94.0% above the low of $13.74 (24 Feb 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−9.5%

6 months−0.8%

1 year−37.7%

5 years+219.7%

Newswire

About

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Website

Notable moves

March 9, 2026
+40.79%
June 23, 2025
−34.63%
February 27, 2024
+31.02%

Newswire

About

Website

Notable moves

March 9, 2026
+40.79%
June 23, 2025
−34.63%
February 27, 2024
+31.02%

Hims & Hers Health, Inc.

XNYSHealth care

Last traded price · USD

$26.80

+4.28%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: $25.92
Previous close: $25.70
Volume: 11.6M
Day's high: $28.66
Day's low: $25.92

In brief

Hims & Hers Health, Inc. is a health care company listed on the New York Stock Exchange, valued at about $6.25B.
Its shares closed at $26.66 on 4 Nov 2026, down 37.7% over the past year.
From India you can buy HIMS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Hims & Hers Health, Inc. (HIMS) shares from India?

Do I need the price of a whole HIMS share to invest?

How much can I invest in US stocks in a year?

Can I trade HIMS options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: −9.5% (SPY −1.6%). 3 months: −15.8% (SPY −0.4%). 1 year: −37.7% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: HIMS, SPY · as of 4 Nov 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $26.66 was 7.0% below its 50-day average ($28.66) and 1.1% below its 200-day average ($26.95). It has closed below the 200-day for 3 sessions, since 2 Nov 2026. The 50-day average crossed above the 200-day on 30 Jul 2026, 68 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
5.0 days to cover short interest
53.5M shares were sold short at the 15 Oct 2026 settlement, 23.8% of the 224.9M shares outstanding; covering them would take 5.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
43% of the way up its 52-week range
Closed at $26.66 on 4 Nov 2026: 39.4% below the 52-week high of $44.00 (6 Nov 2025) and 94.0% above the low of $13.74 (24 Feb 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−9.5%

6 months−0.8%

1 year−37.7%

5 years+219.7%

Newswire

About

Website

Notable moves

March 9, 2026
+40.79%
June 23, 2025
−34.63%
February 27, 2024
+31.02%

Newswire

About

Website

Notable moves

March 9, 2026
+40.79%
June 23, 2025
−34.63%
February 27, 2024
+31.02%

Hims & Hers Health, Inc.

Hims & Hers Health, Inc. in brief

Behind SPY over 1 year

Below its 50- and 200-day averages

5.0 days to cover short interest

43% of the way up its 52-week range

Hims & Hers Health, Inc.

Hims & Hers Health, Inc. in brief

Behind SPY over 1 year

Below its 50- and 200-day averages

5.0 days to cover short interest

43% of the way up its 52-week range